HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (3- (4- benzamido- 1H- pyrrolo(3,2- c)pyridin- 1- yl)phenyl)- 4- morpholino- 3- (trifluoromethyl)benzamide

also inhibits MEK and JNK kinases; structure in first source

Also Known As:

KIST101029

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Choi, Hong Seok: 1 article (01/2013)
2.	Choi, Hoo-Kyun: 1 article (01/2013)
3.	Khanal, Prem: 1 article (01/2013)
4.	Kim, Garam: 1 article (01/2013)
5.	Kim, Karam: 1 article (01/2013)
6.	Oh, Chang-Hyun: 1 article (01/2013)
7.	Sohn, Honglae: 1 article (01/2013)
8.	Yun, Hyo Jeong: 1 article (01/2013)

Related Diseases

1.

Neoplastic Cell Transformation

01/01/2013 - "In this study, we demonstrate that a N-(3-(4-benzamido-1H-pyrrolo[3,2-c]pyridin-1-yl)phenyl)-4-morpholino-3-(trifluoromethyl)benzamide, KIST101029, inhibits neoplastic cell transformation induced by insulin-like growth factor 1 (IGF-1) in mouse epidermal JB6 Cl41 cells. "
01/01/2013 - "Inhibitory effects of a new 1H-pyrrolo[3,2-c]pyridine derivative, KIST101029, on activator protein-1 activity and neoplastic cell transformation induced by insulin-like growth factor-1."

Related Drugs and Biologics

1.	Morpholinos
2.	Insulin-Like Peptides
3.	benzamide
4.	Transcription Factor AP-1 (Transcription Factor AP 1)
5.	Insulin (Novolin)
6.	pyridine